Home
Scholarly Works
Secukinumab 300 mg demonstrates highest...
Conference

Secukinumab 300 mg demonstrates highest probability of efficacy than other biologics in psoriasis: indirect comparison

Authors

Collins A; Hawe E; Vickers A; Mallya UG; McBride D; Capkun-Niggli G; Olson M; Thorlund K

Volume

56

Pagination

pp. 27-28

Publisher

WILEY-BLACKWELL

Publication Date

May 1, 2015

Conference proceedings

AUSTRALASIAN JOURNAL OF DERMATOLOGY

ISSN

0004-8380

Labels

Fields of Research (FoR)

Contact the Experts team